久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Takeda Issues US Recall of NATPARA americanpharmaceuticalreview
    September 09, 2019
    Takeda Pharmaceutical announced the company is issuing a US recall for all doses of NATPARA? (parathyroid hormone) for Injection (25 mcg, 50 mcg, 75 mcg, and 100 mcg).
  • Takeda recalls eye drug Natpara but warns patients not to abruptly stop treatment fiercepharma
    September 08, 2019
    Takeda Pharmaceutical’s been looking for a buyer for Natpara to?provide some debt relief, but it has just run into some complicating circumstances. It is having to recall the eye drug from the market, a move it says may be very challenging for patients.??
PharmaSources Customer Service